Senator SENN proposed the following amendment (150R037.SP.SS):

Amend the bill, as and if amended, on page 3, lines 7 through 9, by striking Section 44-53-2010(1)(a)(iii) and inserting:

/ (iii) cannabis products for use in an inhaler that contain a metered dose of no more than eight thousand, two hundred milligrams of delta-9-tetrahydrocannabinol. This provision shall not be construed as allowing cannabis products for use by vaporization; or /

.

Amend the bill further, as and if amended, beginning on page 39, lines 29 through 42, and page 40, lines 1 through 10, by striking Section 44-53-2350(D) and inserting:

/ (D)(1)After consulting with public health experts, medical professionals, and analysts who conduct health and safety research on cannabis inhalers and reviewing some other states' regulations on medical cannabis inhalers, the department shall promulgate regulations to foster the health and safety of patients using medical cannabis inhalers. The regulations may include:

(1)mandating that all models of inhalers sold by dispensaries be subject to laboratory testing, including stress tests and shelf-life tests;

(2)requiring laboratory testing of medical cannabis inhaler cartridges that are allowed to be used with inhaler devices, including testing of the aerosolized products;

(3)creating a list of any non-cannabis ingredients that are permitted to be included in medical cannabis inhalers, which have been identified as safe for inhalation, and specifying the proportion of those ingredients that are allowed in each cartridge;

(4)issuing standards for heavy metals or plastics included in hardware; and

(5)developing warning labels that must be included on inhalers, detailing any known risks.

(2) This subsection shall not be construed as applying to methods of vaporization. /